Sort
48,018 grants matching “immunotherapy”
Clinical trials employing cancer vaccine combination therapies
$715,531James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Final preclinical development of an immunoadhesin therapy for inhalation anthrax
$715,128Keith Wycoff · Planet Biotechnology, Inc. · R01 · FY2013 · AI
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$715,124Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2020 · AI
PASSIVE IMMUNITY TO COCAINE USING NOVEL HUMAN ANTIBODIES
$715,114University Of Cincinnati · U19 · FY2000 · DA
Development of Novel Immunotherapeutic Strategies for Myeloid Malignancies
$715,080Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2022 · AI
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2024 · AI
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2023 · AI
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2025 · AI
Targeting virus-specific CAR T cells to lymphoid follicles to achieve durable HIV suppression
$714,949Pamela J Skinner · University Of Minnesota · R01 · FY2022 · AI
Targeting virus-specific CAR T cells to lymphoid follicles to achieve durable HIV suppression
$714,949Pamela J Skinner · University Of Minnesota · R01 · FY2023 · AI
Technology/Map Endothelial Targets/Human Renal Tumors
$714,748Jan E Schnitzer · Sidney Kimmel Cancer Center · R33 · FY2006 · CA
Phenotypic variability within isogenic population of lymphocytes
$714,745Gregoire Altan-Bonnet · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes
$714,705Alphonsus Ng · University Of Utah · R01 · FY2023 · DK
TGIB Surgical Oncology Fellowship Program
$714,676David Schrump · Division Of Basic Sciences - Nci · ZIE · FY2014 · CA
Gene Transfer and Somatic Cell Engineering Core
$714,375Isabelle Riviere · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Therapeutic targeting MDSC-mediated immune suppression in cancer
$714,368Yulia Nefedova · Wistar Institute · R01 · FY2022 · CA
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
$714,234Obi L. Griffith · Washington University · U24 · FY2023 · CA
Beta-Amyloid Immunization in a Canine Model of Aging
$714,224Elizabeth Head · University Of Kentucky · R01 · FY2011 · AG
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$714,132Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Novel Targets for Vaccine Therapy
$714,123Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Investigating hypoxia as a determinant of malignant fates in pancreas cancer
$714,122Tuomas Tammela · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$714,052Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2024 · CA
The Biology of Mutant STAT6 in Follicular Lymphoma
$713,700Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Homologous recombination repair pathway mutations and genetic mechanisms shaping anti-tumor immunity and immunotherapy efficacy
$713,601Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA